78
40
Growth Score
-8 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3730773
Ribomic is a research and development company that provides new drugs for diseases.
- Yoshikazu Nakamura: Founder, President and CEO
About the Company
RIBOMIC develops molecularly targeted pharmaceutical drugs using RNA aptamers. The co-discovery division earns the alliance partner's research expenses for the shared part of co-discovery business with alliance pharmaceutical companies researching aptamer pharmaceutical.
